The hospital infection therapeutic landscape is segmented by drug type into antibacterial, antiviral, and antifungal therapies, with antibacterial drugs dominating due to the high incidence of bacterial infections in healthcare settings. The Hospital Infection Therapeutic Market size is expected to reach US$ 16.2 Billion by 2031. The market is anticipated to register a CAGR of 3.3% during...